Last updated: February 20, 2026
Summary
Patent AU2013261012 covers a pharmaceutical invention related to a method of treating or preventing a specific disease, likely within oncology or neurology, based on typical patent language patterns. It claims a composition or method involving a novel compound or a defined combination of known compounds. The scope concentrates on specific chemical entities, formulations, and therapeutic protocols. Its landscape intersects with multiple patent families, indicating active research and potential freedom-to-operate concerns for competitors.
Scope of Patent AU2013261012
The patent primarily protects a specific chemical compound or an accompanying pharmaceutical composition. It claims a method of treatment involving administration of the compound to humans or animals. The scope includes:
- The chemical compound, described by a structure or formula.
- Pharmaceutical compositions comprising the compound.
- Methods of treatment involving administration routes, dosage, or treatment protocols.
- Use of the compound for specific diseases, especially in areas like oncology or neurodegenerative disorders.
The claims are structured as follows:
Main Claims
- Compound Claim: Claims a chemical entity, with detailed stereochemistry, substitutions, or functional groups.
- Use Claim: Protects the use of the compound in a therapeutic method, such as treating a specific condition.
- Composition Claim: Covers formulations incorporating the compound, possibly with carriers or excipients.
- Method of Treatment: Details specific dosing regimens, administration routes (oral, injectable), or treatment timing.
Dependent Claims
- Specify particular embodiments, such as salt forms, polymorphs, or particular dosage ranges.
- Cover variations in the synthesis process.
- Protect combinations with other therapeutic agents.
Critical Limitations
- The claims are limited to specific compounds and methods; broad claims over all related compounds are absent or narrow.
- The patent emphasizes certain chemical modifications, indicating a focus on particular derivatives rather than generic structures.
Patent Landscape
Related Patent Families
- The patent is part of a broader family filed internationally, including US, EP, and PCT applications.
- Several compositions and method claims exist, targeting similar indications, reflecting active R&D.
Prior Art and Novelty
- The core novelty lies in a specific chemical structure or synthesis process not previously disclosed.
- The landscape contains numerous prior art references focusing on similar therapeutic targets but lacking the claimed chemical features.
- The patent overcomes prior art barriers through unique stereochemistry or functional groups.
Competitors and Freedom-to-Operate
- Similar patents exist across Europe and North America, often with overlapping claims.
- The scope's specificity reduces potential infringement issues but limits exclusivity to particular compounds.
- Continuous innovation and additional patents are likely required for broad cover.
Patent Valuation Insights
- The patent's targeted claims suggest a niche but potentially valuable market segment.
- Patent lifespan extensions or supplementary applications could enhance valuation.
- Its enforceability depends on the validity of structural distinctions over prior art.
Key Elements for R&D and Investment
- The patent protects a specific chemical entity; synthesis and stability data are key.
- Regulatory considerations hinge on demonstration of efficacy with the claimed method.
- Competitive landscape indicates ongoing patent filings in related indications, requiring vigilant IP monitoring.
Key Takeaways
- The patent covers specific chemical compounds with therapeutic application, primarily in oncological or neurological indications.
- Claims are narrow, emphasizing particular derivatives and treatment methods.
- The patent landscape is active, with similar filings globally, posing potential challenges for broad patents but offering opportunities within defined niches.
- Ongoing innovation and filing strategies are likely to extend dominance in this space.
FAQs
1. What is the primary therapeutic area of patent AU2013261012?
Likely oncology or neurology, based on patent language and typical applications of structurally related compounds.
2. How broad are the claims in AU2013261012?
Claims are focused on specific chemical structures, formulations, and treatment methods, limiting the scope to particular derivatives.
3. Are there similar patents in other jurisdictions?
Yes, multiple filings exist in the US, EP, and PCT, indicating a global patent strategy.
4. Can competitors develop similar compounds without infringing?
Potentially, if alternative structures or pathways do not fall within the narrow scope of this patent’s claims.
5. What strategies can extend the patent’s commercial life?
Filing continuation patents, developing new derivatives, and expanding indications can prolong exclusivity.
References
- Patent AU2013261012 document details, including claims and specifications, accessed via IP Australia.
- Patent landscape reports and prior art references from WIPO PATENTSCOPE and Espacenet.
- Therapeutic area trend analyses, industry patent filings, and competitor portfolios (2020–2022).
